[MBLX] Metabolix, Inc.

Overview

Type of security: Stock

Sector: Basic Industries

Industry: Containers/Packaging

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 0.37 Change: -0.06 (-13.95%)
Ext. hours: Change: 0 (0%)

chart MBLX

Refresh chart

Description: Metabolix, Inc., a bioscience company, focuses on delivering sustainable solutions to the plastics and chemicals industries. It produces a family of biopolymers found in nature called polyhydroxyalkanoates, which occur naturally in living organisms and are chemically similar to polyesters. The company offers its biopolymers under the Mirel and Mvera brand names. It is also developing biobased industrial C4 and C3 chemicals; and harnessing the renewable nature of plants to make renewable chemicals and bioenergy from crops. Metabolix, Inc. was founded in 1992 and is based in Cambridge, Massachusetts.

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 5.22% Sales Growth - Q/Q-24.65% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-164.88% ROE-206.19% ROI
Current Ratio4.84 Quick Ratio4.66 Long Term Debt/Equity Debt Ratio0.24
Gross Margin55.53% Operating Margin-724.09% Net Profit Margin-734.89% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities-130 K Cash From Operating Activities-6.66 M Gross Profit560 K
Net Profit-5.84 M Operating Profit-5.83 M Total Assets16.67 M Total Current Assets15.43 M
Total Current Liabilities3.19 M Total Debt Total Liabilities3.34 M Total Revenue650 K
Technical Data
High 52 week2.21 Low 52 week0.25 Last close0.37 Last change2.78%
RSI58.06 Average true range0.05 Beta1.37 Volume587.77 K
Simple moving average 20 days6.78% Simple moving average 50 days0.33% Simple moving average 200 days-49.16%
Performance Data
Performance Week8.82% Performance Month48% Performance Quart-27.45% Performance Half-53.75%
Performance Year-74.31% Performance Year-to-date5.71% Volatility daily17.13% Volatility weekly38.31%
Volatility monthly78.51% Volatility yearly271.97% Relative Volume330.21% Average Volume118.05 K
New High New Low

News

2018-11-10 05:27:19 | Edited Transcript of MBLX earnings conference call or presentation 8-Nov-18 9:30pm GMT

2018-08-24 21:48:43 | Edited Transcript of MBLX earnings conference call or presentation 9-Aug-18 8:30pm GMT

2018-05-21 22:52:52 | Edited Transcript of MBLX earnings conference call or presentation 10-May-18 8:30pm GMT

2018-03-10 02:06:04 | Edited Transcript of MBLX earnings conference call or presentation 8-Mar-18 9:30pm GMT

2017-11-10 16:17:08 | Edited Transcript of MBLX earnings conference call or presentation 9-Nov-17 9:30pm GMT

2017-08-30 06:27:43 | Edited Transcript of MBLX earnings conference call or presentation 22-Mar-17 8:30pm GMT

2017-08-16 14:28:43 | Edited Transcript of MBLX earnings conference call or presentation 10-Aug-17 8:30pm GMT

2017-05-12 17:50:33 | Edited Transcript of MBLX earnings conference call or presentation 11-May-17 8:30pm GMT

2017-05-11 19:15:58 | Edited Transcript of MBLX earnings conference call or presentation 11-May-17 8:30pm GMT

2017-03-22 07:07:02 | Q4 2016 Yield10 Bioscience Inc Earnings Release - After Market Close

2017-01-06 12:55:45 | METABOLIX, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statem

2017-01-06 09:35:07 | Metabolix, Inc. Announces Name Change to Yield10 Bioscience, Inc.

2017-01-06 09:00:00 | Metabolix, Inc. Announces Name Change to Yield10 Bioscience, Inc.

2017-01-05 16:10:53 | METABOLIX, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

2017-01-04 03:53:05 | Metabolix Granted 180-day Extension by NASDAQ to Regain Compliance with Minimum Bid Price Rule

2017-01-03 16:10:03 | METABOLIX, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T

2017-01-03 16:07:00 | 4:07 pm Metabolix announces the co was granted 180-day extension by Nasdaq to regain compliance with min bid price rule

2017-01-03 16:05:00 | Metabolix Granted 180-day Extension by NASDAQ to Regain Compliance with Minimum Bid Price Rule

2016-12-21 15:04:07 | METABOLIX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders

2016-12-19 13:39:49 | ETFs with exposure to Metabolix, Inc. : December 19, 2016

2016-12-09 12:25:26 | ETFs with exposure to Metabolix, Inc. : December 9, 2016

2016-11-18 13:07:06 | METABOLIX, INC. Files SEC form 10-Q, Quarterly Report

2016-11-16 13:15:47 | ETFs with exposure to Metabolix, Inc. : November 16, 2016

2016-11-11 12:00:03 | Metabolix, Inc. :MBLX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016

2016-11-09 16:21:22 | Metabolix Announces Third Quarter 2016 Financial Results

2016-11-09 16:13:01 | METABOLIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits

2016-11-09 16:05:00 | Metabolix Announces Third Quarter 2016 Financial Results

2016-11-09 07:07:08 | Q3 2016 Metabolix Inc Earnings Release - After Market Close

2016-11-08 16:13:50 | METABOLIX, INC. Files SEC form 8-K, Change in Directors or Principal Officers

2016-11-01 09:15:06 | Metabolix to Conduct Webcast of its Third Quarter Conference Call

2016-11-01 09:00:00 | Metabolix to Conduct Webcast of its Third Quarter Conference Call

2016-10-27 13:27:14 | ETF’s with exposure to Metabolix, Inc. : October 27, 2016

2016-10-19 16:28:06 | METABOLIX, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial St

2016-10-17 16:33:06 | Metabolix to Conduct Conference Call and Live Webcast of Investor Presentation on Yield10 Bioscience

2016-10-17 16:33:06 | Metabolix Names Yield10 Bioscience Management Team; Provides Update on Strategic Restructuring and Cash Position

2016-10-17 16:06:00 | Metabolix to Conduct Conference Call and Live Webcast of Investor Presentation on Yield10 Bioscience

2016-10-17 16:05:00 | Metabolix Names Yield10 Bioscience Management Team; Provides Update on Strategic Restructuring and Cash Position

2016-10-06 11:33:18 | Dr. Kristi Snell Representing Yield10 at Policy Event Focused on Building a 21st Century Agricultural Workforce

2016-10-04 10:06:14 | ETF’s with exposure to Metabolix, Inc. : October 4, 2016

2016-09-29 09:10:10 | Metabolix and North Carolina State University Enter into Worldwide, Exclusive License Agreement for Advanced Crop Technologies

2016-09-29 09:00:00 | Metabolix and North Carolina State University Enter into Worldwide, Exclusive License Agreement for Advanced Crop Technologies

2016-09-27 09:19:02 | Metabolix Names Heike Sederoff, Ph.D. to Yield10 Bioscience Scientific Advisory Board

2016-09-27 09:00:00 | Metabolix Names Heike Sederoff, Ph.D. to Yield10 Bioscience Scientific Advisory Board

2016-09-21 16:07:15 | METABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial S

2016-09-19 16:18:08 | Metabolix Completes $10 Million Sale of Biopolymer Assets to CJ CheilJedang

2016-09-19 16:05:00 | Metabolix Completes $10 Million Sale of Biopolymer Assets to CJ CheilJedang

2016-08-22 16:28:08 | Metabolix Announces $10 Million Binding Letter of Intent for Sale of Biopolymer Assets to CJ CheilJedang

2016-08-22 16:14:44 | METABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial S

2016-08-22 16:05:00 | Metabolix Announces $10 Million Binding Letter of Intent for Sale of Biopolymer Assets to CJ CheilJedang

2016-08-17 13:04:33 | METABOLIX, INC. Financials